Table: begin end state 1 26 signal peptide 27 274 non-cytoplasmic 275 302 transmembrane 303 306 cytoplasmic 307 324 transmembrane 325 328 non-cytoplasmic 329 350 transmembrane 351 361 cytoplasmic 362 380 transmembrane 381 412 non-cytoplasmic 413 431 transmembrane 432 461 cytoplasmic 462 482 transmembrane 483 496 non-cytoplasmic 497 521 transmembrane 522 528 cytoplasmic 529 548 transmembrane 549 564 non-cytoplasmic
Input: >WP_014148243.1 NCBI__GCF_000968535.2:WP_014148243.1 MKADSFKWRMSLLALLMLCVRPGIALDESTAETADSQEVSEQQAETVLDPFADALARLIS GSMKEREQASEQLSVTGHSEALPILEALLDGRLYALRDKQTAVIATESGQGYRIAEASTG SDLGLVERSDLSKVNITNSLRTKLRKKISLLQLQSDDASVRLSAVNAMVKTADAKTLELL KEYESTESDEDVLSSMRLIFALNDLQNSDKSVRLDAMDTLKEYNSLEAYNRLSVLVEKDS AGNFIEQDVEVRKKAQSALKKIEARLQFYNSVETMFFGLSLGAVLVLAAIGLAITFGVMG VINMAHGELMMLGAYTTYVMQQIMPNHIGLSVILAIPAAFMISALVGVAIERGIIRFLYG RPLETLLATFGISLFLQQTVRSIFSPLNRSVTTPEWMSGSWQINDFLSLTWNRFYIVLFC LLVFAALLQILKKTRLGLEVRAVAQNRNMAKAMGIPTARVDAMTFGLGSGIAGVAGVALS QITNVGPNLGQSYIVDSFMVVVFGGVGNLWGTLVAGFSLGIANKMLEPHAGAVLAKILVL VFIILFIQKRPRGLFPQKGRAAEA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server